in patients with zollinger-ellison syndrome , the potency and long duration of action of famotidine may confer an advantage over other h2-receptor antagonists -- in individualised doses ( mean 0.33 g/day ) famotidine successfully controlled acid secretion for up to 72 months in 1 study of such patients .
C0043515
zollinger-ellison syndrome
C0015620
famotidine